While you’re here… help us stay here.
Are you enjoying open access to policy and research published by a broad range of organisations? Please donate today so that we can continue to provide this service.
|Patient power: unleashing choice over routine medications||1.25 MB|
When the NHS in England considers how to build back from its crisis response to the COVID-19 pandemic, there is an opportunity to reconsider the nature of the ongoing relationship between patient and doctor, and in particular the way in which routine medications are prescribed.
This report finds that many patients are not fully aware of the level of control they are entitled to when it comes to choosing medication. It suggests that pharmacists could play a greater role in the patient care pathway to support patients make choices about their medication, where doctors do not have the time or capacity.
The research has found that 61% of the public support joint decision making between patient and doctor when it comes to choosing medication, but that an even larger majority of the public (74%) believe that the final decision ultimately lies with the doctor. Half of these people (36% of the total population) believe their own preferences are not relevant to that decision at all.
The research also found that a large majority (62%) of the population were satisfied with their personal level of involvement in deciding their most recent medication, however a significant proportion (30%) of the population wanted to be more involved.
The report shows the need for the medical profession to continue to encourage and enable patients to be more involved in the choice of medication, as it would improve financial efficiency, medical efficacy, and is more ethical.